European regulatory issues in nanomedicine

NanoEthics

Volumn 2, Issue 1, 2008, Pages 87-97

  Guerra, Giorgia ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Medical ethics; Nanomedicine; Risk perception; Technology regulation

Indexed keywords

EID: 41149152732     PISSN: 18714757     EISSN: 18714765     Source Type: Journal    
DOI: 10.1007/s11569-008-0031-1     Document Type: Article

References (30)

1. Abbott KW, Marchant, GE, Sylvester DJ (2006) A framework convention for nanotechnology? Environ Law Report 36 (article 777). http://ssrn.com/ abstract=946777
2. Bayiley, R Rebels (2004) Against the future: Witnessing the birth of the global anti-technology movement (Reason Online). http://reason.com/rb/ rb022801.html. Cited October 2006
3. Beck U (2000) La società del rischio. Verso una nuova modernità (Italian version). Carocci, Roma
4. Berenghi A (1992) In merito alla responsabilità del produttore, importatore e fornitore di farmaci dannosi per la salute. Nuova giur civ 569
5. Best R, Khushf G (2006) Symposium article: Ethical and social issues integral to the development of specific initiatives in nanotechnology: the social conditions for nanomedicine: Disruption, systems, and lock-in. J Law Med Ethics 34:733
6. Bucchi M (2006) Scegliere il mondo che vogliamo. Cittadini, politica, tecnoscienza. il Mulino, Bologna
7. Carnevali U (2006) Consegna del prodotto al distributore e "messa in commercio" di esso. Resp civ e prev, 831
8. Castel R (1991) From dangerousness to risk. In: Burchell G, Gordon G, Miller P (eds) The Foucault effect: Studies in governmentality. University of Chicago Press, Chicago
9. Chai JY (2000) Medical device regulation in the United States and the European Union: A comparative study. Food Drug Law J 55:57-80
10. Foote SB, Berlin RJ (2005) Can regulation be as innovative as science and technology? The FDA's regulation of combination products. Minn J Law Sci Tech 6:619
11. Horton LR (1993) Over the Counter Drug Authority Issues: Selected Topics. Food Drug Law J 48:545
12. Izzo U (2006) Danno lungolatente alla persona e decorrenza della prescrizione nell'azione risarcitoria ruolo dell'informazione ed oneri probatori. In: Izzo U (ed) Dialoghi sul danno alla persona. Università degli Studi di Trento, Trento, p 257
13. Izzo U (2004b) La precauzione nella responsabilità civile. Analisi di un concetto sul tema del danno da contagio per via trasfusionale. Cedam, Padova
14. Joerges C, Ladeur K-H, Vos E (eds) (1997) Integrating scientific expertise into regulatory decision-making. National traditions and European innovations. Baden-Baden: Nomos, pp 295-323
15. Khushf G, Wilson R (2006) Symposium article: Introduction a sympathetic but critical assessment of nanotechnology initiatives. J Law Med Ethics 34:655
16. Kurzweil VR (1999) The age of spiritual machines: When computers exceed human intelligence. Penguim, New York
17. Lavender M (2005) Regulating innovative medicine: Fitting square pegs in round holes. Duke Law Tech Rev 1
18. Lin AC (2006) Size matters: Regulating nanotechnology. US Davis Legal Studies Research. Paper 635. http://ssrn.com/abstract=934635. Cited October, 2006
19. Marchetti B (2005) Pubblica amministrazione e corti negli Stati Uniti. Il judicial review sulle administrative agencies. Cedam, Padova
20. Noah B (2004a) Bioethical malpractice: Risk and responsibility in human research. J Health Care Law Policy 7:175
21. Noah L (2003b) Challenges in the federal regulation of pain management technologies. J Law Med Ethics 31:55
22. Pascuzzi G (2006) Il diritto dell'era digitale. Tecnologie informatiche e regole privatistiche. il Mulino, Bologna, p 208
23. Reimann M (2003) Liability for detective products at the beginning of the twenty-first century: Emergence of a worldwide standard? Am J Comp Law 51:571
24. Reynolds GH (2003) Nanotechnology and regulatory policy: Three futures. Harv J Law Tech 17:179
25. Rodotà S (2006) La vita e le regole Tra diritto e non diritto. Feltrinelli, Milano, p 193
26. Sieff B (2004) Rigenerazione di dispositivi medici e responsabilità - Profili di regolamentazione nella normativa comunitaria ed italiana. Danno e responsabilità, 772
27. Sunstein CR (1996) Health-health tradeoffs. Univ Chic Law Rev 63:1533
28. Viscusi WK, Harrington JE, Vernon JM (2005) Economics of regulation and antitrust. MIT, Cambridge
29. Wynne B (1992) Uncertainty and environmental learning: Reconceiving science and policy in the preventive paradigm. Glob Environ Change 111
30. Zhou W (2003) Ethics of nanobiotechnology at the frontline. Santa Clara Comput High-Technol Law J 19:481